BradyLAB BRD - Cryogenic Labels · Biobank Identification Specialists

Biobank Label System Selection: Barcode/2D Code/RFID Comparison

As core infrastructure for precision medicine and life science research, the reliability of a biobank's identification system directly affects sample quality management and full-process traceability. In its best practice guidelines, the International Society for Biological and Environmental Repositories (ISBER) explicitly states that all cryopreserved samples must use an identification carrier capable of withstanding the storage environment, and recommends barcodes or radio frequency identification (RFID) technology for automated tracking. GB/T 37864-2019 "General requirements for the quality and competence of biobanks" (identical to ISO 20387:2018) likewise requires that sample identification be unique and that the identification carrier withstand extreme temperature changes from -196 °C liquid nitrogen to ambient temperature.

However, faced with three mainstream technology routes—1D barcodes, DataMatrix 2D codes, and RFID electronic tags—many biobank managers find the choice confusing: which solution better suits their sample types and storage scale? BradyLAB BRD, a professional brand in the field of laboratory cryogenic labels, has deep experience in biobank identification applications. Based on practical project experience, this article systematically compares the performance characteristics and applicable scenarios of the three technologies.

1. Comparison of core parameters of three identification technology routes

Comparison dimension1D barcode (Code 128)DataMatrix 2D codeRFID electronic tag
Data capacityApprox. 48 charactersUp to 3116 numeric charactersTypically 512 bit–8 KB
Error correctionNone (relies on check digit)ECC200 error correction, recovers up to 30% damageBuilt-in chip verification
Reading methodLaser/CCD scan, line of sight requiredImage-based scanning, line of sight requiredRF reading, no line of sight required, penetrates containers
Batch readingScan one by oneScan one by oneSupports batch reading of whole boxes/racks
LN₂ compatibilityLabel must withstand low temperatures; barcode itself unaffectedLabel must withstand low temperatures; 2D code itself unaffectedMost RFID tags withstand only -80 °C; performance degrades in LN₂
Label sizeRequires a longer print areaExtremely small area sufficient (2-3 mm²)Chip + antenna, larger size
Cost per labelLow (approx. ¥0.1–0.3)Low (approx. ¥0.1–0.5, including pre-printed 2D code cryovials)Higher (¥2–10 each)
Equipment investmentBarcode scanner, several hundred yuan2D scanner, several thousand yuanRFID reader/writer, tens of thousands of yuan
Applicable standardsISO/IEC 15416ISO/IEC 15415 (Grade A requires ≥3.5)ISO/IEC 18000-6C (EPC Gen2)

2. 1D barcodes: lowest cost, suitable for small biobanks getting started

1D barcodes (such as Code 128) are the most traditional identification solution, with mature technology and low equipment investment. In biobanks, 1D barcodes are usually printed on the label surface and contain key information such as sample ID and collection date. Their advantage lies in a low implementation threshold, inexpensive scanning equipment, and broad compatibility with mainstream LIMS systems.

But the limitations of 1D barcodes are also obvious: first, limited information capacity (approx. 48 characters), which cannot store complete metadata and requires database queries; second, the barcode is long and difficult to print clearly on the small surface area of 0.5 mL–2 mL cryovials; third, there is no error correction, so once the label is partially soiled or damaged, it may become unreadable.

BradyLAB BRD 1D barcode cryogenic labels use a -196 °C-resistant cryogenic PET face stock and specialized adhesive, are compatible with Code 128 format printing, and, paired with BradyLAB BRD thermal-transfer printers, achieve 600 dpi high-resolution output to meet the daily identification needs of small biobanks.

3. DataMatrix 2D codes: the current mainstream solution for biobanks

DataMatrix 2D codes are currently the most widely used identification technology in biobanks worldwide. Their core advantages include:

1. Ultra-high information density: DataMatrix can encode up to 3116 numeric characters or 2335 alphanumeric characters within an area of only 2-3 square millimeters, far exceeding the information density of QR Code in the same area. This makes it possible to print a complete sample ID on the bottom of a cryovial (typically 8-12 mm in diameter).

2. ECC200 error correction mechanism: DataMatrix incorporates a built-in Reed-Solomon error correction algorithm; even if 30% of the label surface is covered by frost or physically scratched, scanning equipment can still read it successfully. This feature is extremely critical in scenarios where frost forms on the label surface after removal from liquid nitrogen.

3. International standard compatibility: ISO/IEC 15415 defines four grades—A/B/C/D—for 2D code quality, and biobanks typically require Grade A (≥3.5) to ensure reading reliability after long-term storage. Pre-printed 2D code cryovials (such as Thermo Scientific Matrix, Micronic, and other brands) have been widely deployed in biobanks worldwide.

BradyLAB BRD 2D code cryovial labels support DataMatrix GS1 standard format encoding; the labels use a wrap-around design or bottom-labeling method and are compatible with standard cryovial specifications such as 0.5 mL/1.5 mL/2 mL/5 mL. BradyLAB BRD cryogenic labels do not become brittle or detach after long-term immersion in -196 °C liquid nitrogen, and the 2D code scan recognition rate remains above 99.9% after repeated freeze–thaw cycles. Paired with BradyLAB BRD dedicated resin ribbons, print resolution reaches 600 dpi, meeting the ISO/IEC 15415 Grade A quality standard.

4. RFID electronic tags: the future direction of automated sample management

RFID (radio frequency identification) electronic tags represent the next-generation solution for biobank identification technology. Compared with barcode technology, the core advantages of RFID are:

No line of sight required: RFID readers/writers read chip data via RF signals; even if the tag is obscured by a cryobox or located deep in a rack, it can still be read quickly.

Batch reading capability: An RFID system can complete an inventory scan of a whole box (96 vials) or a whole rack of cryovials within seconds, improving efficiency dozens of times over scanning one by one. For large biobanks managing hundreds of thousands of samples, this can significantly reduce manual operation time and the frequency with which samples are exposed to room temperature.

Writable data: RFID tag chips support repeated read/write, allowing dynamic information such as operation records and temperature logs to be appended at different stages of the sample lifecycle.

However, RFID application in biobanks also faces challenges: most commercial RFID tags have unstable performance in -196 °C liquid nitrogen environments, and chips and antennas may fail at extreme low temperatures. Currently, the industry's mainstream approach is to use RFID tags in -80 °C ULT freezer storage environments, while liquid nitrogen storage still relies mainly on 2D code labels. In addition, the equipment investment for a complete RFID system (printer + reader/writer + antenna) is relatively high, offering low cost-effectiveness for small and medium-sized biobanks with limited budgets.

BradyLAB BRD is actively developing a next-generation RFID cryogenic label solution suitable for -196 °C liquid nitrogen environments. Leveraging BradyLAB BRD's technical accumulation in cryogenic materials science, the goal is to overcome the challenge of stable long-term RFID tag operation in liquid nitrogen.

5. Selection recommendations for different biobank scales

Biobank scaleSample volumeRecommended identification solutionBradyLAB BRD product match
Small/research group<10,0001D barcode + manual managementBRD cryogenic barcode labels + desktop thermal-transfer printer
Medium/department level10,000–100,000DataMatrix 2D code + LIMS integrationBRD 2D code cryovial labels + mid-range thermal-transfer printer + barcode scanner
Large/hospital level100,000–1,000,0002D code primary, RFID pilotBRD full range of cryogenic labels + industrial printer + automated labeling solution
Extra-large/regional center>1,000,0002D code + RFID hybrid, automated storage systemBRD customized label solution + system integration services

6. Four key tests for label selection

Regardless of which identification technology is chosen, the physical performance of the label itself is the foundation of system reliability. BradyLAB BRD recommends the following four tests during selection:

1. Liquid nitrogen immersion test: Apply the printed label to a cryovial, immerse in liquid nitrogen for at least 72 hours (30 days or more recommended where possible), then remove and return to room temperature to check whether the label lifts, detaches, or becomes illegible.

2. Freeze–thaw cycle test: Simulate sample access scenarios by removing a labeled cryovial from -196 °C liquid nitrogen → leaving at room temperature for 30 minutes → returning to liquid nitrogen, for more than 10 cycles, then check label adhesion and 2D code readability.

3. Chemical resistance test: Wipe the label surface with commonly used laboratory solvents (75% ethanol, isopropanol, DMSO, etc.) and check whether the printed information fades or is wiped off.

4. Scanning compatibility test: Use scanning devices from at least two different brands to read the labels, ensuring good cross-device compatibility and a stable recognition rate above 99%.

Only labels that pass the above tests have the foundation for reliable long-term use in actual biobanks. The full range of BradyLAB BRD cryogenic labels has been verified through the above four tests and has been validated in actual applications in the biobank projects of multiple biopharmaceutical companies and research institutes.

BradyLAB BRD biobank cryogenic label solution

Featured Products

For the label materials and application scenarios covered in this article, the following BradyLAB (BRD) products are available for selection reference (click to view specifications and request a quote):

7. FAQ: Common questions about biobank identification

Q: Which is better, pre-printed 2D code cryovials or on-site printed labels?

A: Each has its advantages. Pre-printed 2D code cryovials (with laser-etched DataMatrix codes on the bottom) perform excellently in low-temperature resistance and long-term stability, and are suitable for standardized management of large-scale biobanks, but the encoding rules are fixed and flexibility is lower. On-site printed labels can be flexibly encoded according to actual needs, suitable for scenarios with variable encoding rules or diverse sample types. BradyLAB BRD offers both pre-printed custom and on-site printing modes to suit the operational needs of biobanks of different scales.

Q: Do liquid-phase and gas-phase liquid nitrogen storage have the same label requirements?

A: No. Liquid-phase storage (samples directly immersed in liquid nitrogen, -196 °C) places the highest demands on label low-temperature resistance and sealing, as the label must withstand the stress of liquid nitrogen vaporizing and expanding after infiltration. Gas-phase storage (samples in the nitrogen vapor layer above the liquid nitrogen, approx. -150 °C to -190 °C) has relatively lower requirements. BradyLAB BRD's cryogenic label series has an adhesive formulation specially optimized for liquid-phase liquid nitrogen storage, ensuring no detachment under extreme conditions.

Q: How large is the gap between domestic cryogenic labels and imported brands?

A: In the past, the domestic cryogenic label market was mainly occupied by imported brands such as Brady and GA International (LabTAG). In recent years, domestic brands represented by BradyLAB BRD have made significant breakthroughs in cryogenic materials, adhesive formulations, and printing compatibility. The performance indicators of BradyLAB BRD cryogenic labels (liquid nitrogen resistance, number of freeze–thaw cycles, 2D code readability) have reached internationally advanced levels, while offering more flexible customization capabilities and more competitive pricing, providing domestic biobanks with a cost-effective domestic substitution path.

Related Articles

« Back to list